The Indian healthcare and medical device sectors have grown significantly in the last decade. The rising number of medical facilities in India are boosting the demand for medical devices in the market. The Indian medical devices industry was granted the status of an ‘independent industry’ in 2014 and given the title of ‘sunrise’ sector under the Make in India scheme in 2014.
The size of the Indian medical devices market is estimated at Rs. US$ 15.35 billion in 2023 and is expected to grow to US$ 20.51 billion by 2029 with a CAGR of 5.35%.
The Indian medical device market share in the global market is estimated to be 1.65%.
Diagnostic equipment market to reach to US$ 6 billion by 2027, up from US$ 4 billion in CY23.
India is the 4th largest Asian medical devices market after Japan, China, and South Korea, and among the top 20 medical devices markets globally.
In the Union Budget 2025-26, Rs. 99,858 crore (US$ 11.48 billion) was allocated as a budget for the healthcare sector.
In the fiscal year 2022-23, India exported medical consumables and disposables worth US$ 1.6 billion, surpassing imports valued at around US$ 1.1 billion. Exports witnessed a 16% increase, while imports experienced a 33% decline.
The Drugs Controller General of India (DCGI), Dr. Rajeev Raghuvanshi, announced that 11 countries have already recognized Indian pharmacopoeia as their standard. He highlighted that India supplies drugs, vaccines, and medical devices to over 200 countries globally and is now approving, on average, 100 global clinical trials annually, reflecting the trust international research organizations and companies place in India’s regulatory system.
India's reliance on imported medical devices surged between Nov 2022 and Oct 2023, with a 21% increase in imports totalling Rs. 61,262.84 crore (US$ 7.237 billion).
FDI inflow in the medical and surgical appliances sector stood at Rs. 25,959.25 crore (US$ 3,735.93 million) between April 2000-September 2024.
Union Chemicals and Fertilisers Minister JP Nadda launched a Rs. 500 crore (US$ 59.24 million) scheme to boost India's medical devices industry, focusing on manufacturing key components, skill development, clinical studies support, common infrastructure, and industry promotion.
In April 2024, Amkay Products who manufactures, assembles and markets a comprehensive portfolio of medical devices, came with an IPO to raise Rs. 12.6 crore (US$ 1.51 million).
In March 2024, Mr. Mansukh Mandaviya Inaugurates 27 Greenfield Bulk drug park projects and 13 Greenfield Manufacturing Plants for Medical Devices under the PLI scheme.
In February 2024, OMRON Corporation announced that its corporate brand OMRON has received well-known trademark status in India, as recognized by the Registrar of Trademarks. This designation acknowledges the brand's significant nationwide recognition within the country.
In December 2023, MedTech Mitra an online platform was launched to support medtech innovators with clinical assessment, regulatory help, and product adoption.
In November 2023, National Medical Policy, six strategies have been formulated to maximize the sector's potential, along with a detailed action plan for their execution.
In May 2023, Export Promotion Council for Medical Devices was established medical devices, under the Department of pharmaceuticals, with its headquarters in Noida.
In March 2024, Mr. Mansukh Mandaviya, Union Minister for Chemicals & Fertilizers and Health & Family Welfare inaugurated 27 new Bulk Drug Park projects and 13 Manufacturing Plants for Medical Devices under the PLI Scheme. The medical device parks are expected to reduce manufacturing costs as these will be equipped with the necessary infrastructure where companies can plug and play.
On December 2023, Agappe,2023 Kerala’s leading diagnostic technology brand, unveils its first indigenously manufactured HX series haematology equipment and Mispa i200 Immunology CLIA analyser, marking a new era in diagnostics era.
In November 2023, LTTS partnered with Nvidia to create AI-driven, software-based designs for endoscopy devices, aiming to improve image quality and scalability. This collaboration was disclosed in a regulatory filing by the engineering services firm.
In October 2023, Primary Healthtech Pvt. Ltd., a start-up founded by Indian Institute of Technology (IIT) Guwahati alumni, created MobilabTM, a POCT device for early diagnosis of various chronic diseases.
In August 2023, Union Health Minister Mr. Mansukh Mandaviya said that India is poised to become a global centre for medical technology and devices, while addressing the India MedTech Expo 2023.
In August 2023, Manipal Academy of Higher Education (MAHE), Manipal and Siemens Healthineers signed a Master Research collaboration (MRA) for continued strengthening of future cooperation between both organisations in achieving shared outcomes for the stakeholders.
As announced in August 2023, Omron Healthcare India Pvt. Ltd., a subsidiary of Japanese company Omron Healthcare Co. Ltd., which is in the supply of home healthcare monitoring devices in India, is planning to double its revenue in 3-5 years.
In August 2023, Omron Healthcare India announced a collaboration with supermodel, film producer, and fitness enthusiast Mr. Milind Soman to enhance awareness around adopting home monitoring as an essential constituent of the health regime.
In May 2023, Medtronic announced an investment of approximately Rs. 3,000 crore (more than US$ 350 million) to expand the Medtronic Engineering & Innovation Centre (MEIC) in Hyderabad. MEIC is Medtronic’s largest research and development (R&D) centre outside of the US.
In May 2023, Omron Healthcare, a Japan-based manufacturer, and distributor of personal healthcare products, announced that it will set up a medical device manufacturing plant in Tamil Nadu at a cost of Rs. 128 crore (US$ 15.5 million).
In April 2023, Health vista India, the parent company of the healthtech startup Portea Medical, received approval from the Securities and Exchange Board of India (SEBI) for its initial public offering (IPO). The IPO comprises a fresh issue of equity shares worth Rs. 200 crore (US$ 24 million) and an offer for sale (OFS) of up to 56,252,654 shares worth Rs. 800 crore (US$ 95.9 million).
In March 2023, SMT was selected as the exclusive distributor of Penumbra’s peripheral and coronary vascular thrombectomy technologies in select domestic geographies in India.
Medtronic has inaugurated a Medtronic Engineering and Innovation Centre (MEIC) in Hyderabad to leverage India's large pool of diverse and qualified talent to accelerate its innovative work in the medical technology space in the country. It has also announced an investment worth Rs. 1,200 crore (US$ 163 million) to expand its R&D centre facility for medical device software and engineering solutions in Hyderabad, Telangana. This facility will be Medtronic’s largest R&D facility, outside of the US, generating 1,000 jobs in the next five years.
Siemens Healthineers, a global medical technology company, has announced plans to invest Rs. 1,300 crore (US$ 177 million) over the next five years in Bengaluru, Karnataka, to make India one of its four key digital innovation hubs worldwide.
Microtek has announced plans to consolidate its position by expanding their medical devices portfolio. The company forayed into the burgeoning Indian healthcare market by manufacturing products including oxygen concentrators, blood pressure monitors, oximeters, and thermometers, both digital and infrared.
Innovation Imaging Technologies Pvt. Ltd. (IITPL) has established a ‘state-of-the-art’ facility in Bengaluru to manufacture 240 catheterisation laboratories in the next 12 months. Through this initiative, the company aims to strengthen the infrastructure to treat cardio-vascular diseases in the country.
The Government of India has commenced various initiatives to strengthen the medical devices sector, with emphasis on research and development (R&D) and 100% FDI for medical devices to boost the market.
The Union Cabinet approved the National Medical Devices Policy, 2023 on April 26, 2023. The National Medical Devices Policy, 2023 is expected to facilitate an orderly growth of the medical device sector to meet the public health objectives of access, affordability, quality, and innovation.
The Government has tabled a draft for the new Drugs, Medical Devices and Cosmetics Bill 2022, to assure and offer thorough legal protections to ensure that the medical items sold in India are reliable, efficient, and up to required standards.
To boost domestic manufacturing of medical devices and attract huge investments in India, the Department of Pharmaceuticals launched a PLI scheme for domestic manufacturing of medical devices, with a total outlay of funds worth Rs. 3,420 crore (US$ 468.78 million) for the period FY21-28.
In 2022, the PLI Scheme for pharmaceuticals worth Rs. 18,420 crore (US$ 2.24 billion) was launched. This scheme aims to enhance India’s manufacturing capabilities by increasing investment and production in the pharmaceutical and medical devices sectors and contribute to the availability of a wider range of affordable medicines for consumers.
By 2022, the Gautam Budh Nagar, Noida, is expected to have Northern India’s first medical tools and system manufacturing park. The park is likely to be developed in Sector 28 of the Yamuna Expressway Industrial Development Authority (YEIDA) Space by the Yamuna Expressway Authority.
The Tamil Nadu government has proposed to build a medical devices park (spanning 350 acres) near Oragadam in Kancheepuram district worth Rs. 430 crore (US$ 58.92 million). There are other medical parks coming up in Himachal Pradesh, Uttar Pradesh, Punjab, etc.
The Indian Council of Medical Research (ICMR) has collaborated with Indian Institutes of Technology (IITs) to establish ‘ICMR at IITs’ by setting up Centres of Excellence (CoE) for Make-in-India product development and commercialisation in the medical devices and diagnostics space.
References: Government Websites, Press Releases, Media Reports, Deloitte Report
Note: Conversion rate used for January 2025 is Rs. 1 = US$ 0.012
